{"nct_id":"NCT01147536","title":"Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence","status":"TERMINATED","status_verified_date":"2021-05","start_date":"2010-01","start_date_type":null,"primary_completion_date":"2012-06","primary_completion_date_type":"ACTUAL","completion_date":"2012-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AGEN"]}